About
AdOM is a development and commercial stage ophthalmic medical device company which uses hyperspectral technology to measure the dynamics of the tear film inner structures. The TFI is a non-invasive imaging device which is designed to simultaneously measure the muco-aqueous and lipid sublayers of the eye, at a resolution dept of a few nanometers. The TFI has now been registered with the U.S. Food and Drug Administration (under its Class I exemption for this device type)
Technologies
Gmail
Google Apps
Amazon AWS
Cloudflare DNS
CloudFlare Hosting
Bootstrap Framework
Google Font API
Mobile Friendly
Google Maps
WordPress.org
Android
Remote
Laravel
Keywords
medical equipment manufacturing
tear film parameters
tear film stability
dynamic tear film analysis
medical devices
high-resolution tear film measurement
tear film sublayer mapping
lipid layer uniformity analysis
spectral interference imaging
tear film sublayer assessment
spectral interference optical system
tear film thickness trend analysis
healthcare equipment & supplies
non-contact ocular imaging
tear film dynamics during blinking
spectral imaging in ophthalmology
nanometer resolution
large field of view >6.25mm
tear film sublayers
tear film imaging patent portfolio
spectral interference
tear film stability monitoring
nanometer resolution measurement
spectral-model-based interpretation
non-invasive ophthalmic device
tear film health assessment
natural blinking measurement
large field of view imaging
blink rate measurement
muco-aqueous layer thickness
Company Information
-
Employees 13
-
Founded 2008
Location
1 המלאכה, Lod, Center District, Israel, 71520
